Artificial intelligence (AI)-based models developed by a team of international researchers were able to identify ovarian ...

Ophthalmic diseases specialist Oculis Holding AG announced positive phase II data showing its serum-glucose corticoid ...

Small-cell lung cancer accounts for about 10%-15% of all lung cancers, yet its molecular pathogenesis remains largely ...

It was in with the new and out with the old Jan. 3 as the gavel came down on the first session of the 119th U.S. Congress.

The device industry is extraordinarily dependent on administrative activity where Medicare coverage is concerned, and this ...

Altamira Therapeutics Ltd.’s nanoparticle-based delivery platform has been successfully tested for circular mRNA.

Already hot for years, antibody-drug conjugates (ADCs) continued to hold charm for the industry, sparking a number of sizable ...

Roche Holding AG kicked off the new year (again) with a potential $1 billion deal, including $80 million up front, for ...

The Asia Pacific med-tech market is projected to reach $140 billion in 2025 in value, growing roughly 5% per year, driven ...

Ausperbio Therapeutics Inc. raised $110 million from two financing rounds in 2024 to advance its lead antisense ...

From local drug discovery to global innovation, economic uncertainty is taking a toll on China’s innovative biotech system, ...

The U.K. is embarking on the biggest overhaul of clinical trials regulations in 20 years in a bid to retake ground that was lost following Brexit, when the Medicines and Healthcare products Agency was ...